A

ARCUS VENTURES LTD

3 employees

Founded in 2007, Arcus Ventures invests in oncology-focused companies with advanced biopharmaceuticals and is a private equity company.

Investor insights

Sectors invested in

Health Care13
Biotechnology13
Health Diagnostics10
Medical6
biofluids4
exosomes and microvesicles4
diagnostic development4
Medical Device4
biomarkers4
Genetics4
Sepsis3
In-vitro diagnostics3
Infectious Diseases3
Candidemia3
Hemostasis3
Pharmaceutical2
Manufacturing2
Medical Devices1
Guidewire Intravenous Catheters1
IV Catheters1

Funding rounds participated in

$18M sweet spot round size

Most of their 18 investments are in rounds between $9.9M and $27M

Basic info

Industry

accounting

Sectors

Biotechnology
Financial Services
Finance

Date founded

2007

Investments made

E

Exosome Diagnostics raised $30M on July 24, 2017

Investors: Blue Ridge Investment Co, Forbion, Tiger Infrastructure Partners, b-to-v Partners AG and ARCUS VENTURES LTD

E

Exosome Diagnostics raised $16M on January 7, 2016

Investors: Forbion, Blue Ridge Investment Co, QIAGEN and ARCUS VENTURES LTD

E

Exosome Diagnostics raised $18M on September 2, 2015

Investors: Forbion and ARCUS VENTURES LTD

X

XTuit Pharmaceuticals, Inc. raised $22M on June 11, 2015

Investors: Omega Funds, Polaris Partners and ARCUS VENTURES LTD

T

TRACON Pharmaceuticals raised $27M on September 22, 2014

Investors: Nextech Invest, Sahsen Ventures, LLC and ARCUS VENTURES LTD

-

- raised $30M on July 30, 2014

Investors: RMI Partners, Domain Associates and ARCUS VENTURES LTD

E

Exosome Diagnostics raised $27M on March 11, 2014

Investors: b-to-v Partners AG, Forbion, QIAGEN, Tiger Infrastructure Partners and ARCUS VENTURES LTD

U

Undisclosed raised $3.5M on October 2, 2013

Investors: Beringea and ARCUS VENTURES LTD

T

T2 Biosystems raised $40M on March 28, 2013

Investors: Aisling Capital, Polaris Partners, Physic Ventures, Partners Healthcare Group, Flagship Ventures, Flybridge and ARCUS VENTURES LTD

U

Undisclosed raised $9.9M on March 7, 2012

Investors: Beringea and ARCUS VENTURES LTD

FAQ